CureVac is a global biopharmaceutical company with over 20 years of experience in developing mRNA technology for medical purposes. They are revolutionizing mRNA for the betterment of people's lives. As a leading biopharmaceutical company, CureVac strives to develop groundbreaking medications that protect and improve human life.

Powered by their RNA technology platform and two decades of excellence in science and production, they are dedicated to developing novel treatments that enable the body to produce its own prophylactic and therapeutic medicines. They have a diverse pipeline of products and continually publish their findings to advance the field of mRNA technology. CureVac has a global presence and operates from multiple locations worldwide.

Furthermore, they have strong partnerships and are committed to maintaining high standards of corporate governance. Join CureVac's RNA people and be a part of their mission to create innovative medical solutions